mir-27a mimic

miR-27a mimic is a synthetic microRNA designed to mimic the function of endogenous microRNA-27a (miR-27a), a 22-nucleotide non-coding RNA involved in regulating gene expression post-transcriptionally. miR-27a mimics are used primarily as research tools in preclinical studies to increase intracellular levels of miR-27a, enabling scientists to study the effects of miR-27a overexpression in cellular models. miR-27a plays significant roles in oncogenesis, tumor cell metabolism, cell proliferation, invasion, metastasis, and drug resistance, particularly in gastrointestinal and hepatic cancers. It has been implicated in the regulation of drug transporter proteins such as P-glycoprotein (MDR1, ABCB1) and in modulating key signaling pathways including the Wnt/β-catenin and PPARgamma/β-catenin pathways. miR-27a mimics have also been explored for their potential to promote osteogenesis and inhibit muscle atrophy, as well as their therapeutic potential in metabolic, fibrotic, and neurodegenerative diseases[1][4][9].